Correction: Impact of Different Oseltamivir Regimens on Treating Influenza A Virus Infection and Resistance Emergence: Insights from a Modelling Study | Zendy

Open Access

Correction: Impact of Different Oseltamivir Regimens on Treating Influenza A Virus Infection and Resistance Emergence: Insights from a Modelling Study

Publication year - 2014

Publication title -

plos computational biology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.628

H-Index - 182

eISSN - 1553-7358

pISSN - 1553-734X

DOI - 10.1371/journal.pcbi.1003699

Subject(s) - oseltamivir , virology , virus , influenza a virus , medicine , biology , covid-19 , bioinformatics , infectious disease (medical specialty) , disease

There are two corrections to this manuscript: The legend for Figure 2 is incorrect. The complete, correct legend for Figure 2 is: Figure 2. Average oseltamivir carboxylate kinetics (red line: 75 mg, blue line: 150 mg, green: 300 mg). Panel A shows the pharmacokinetics for once a day intake for 10 days and the panel B twice-a-day intake for 5 days. The black line represents the EC 50 for drug-sensitive virus and the dashed line the EC 50 for resistant virus. The EC50s were converted from mMto ng/mL for this figure.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research